Do drug-eluting stents reduce the composite outcome of death from any cause and nonfatal spontaneous myocardial infarction compared to bare-metal stents in patients undergoing PCI?
Drug-eluting stents reduce the need for repeat revascularization compared to bare-metal stents, without a significant difference in hard clinical outcomes like death or myocardial infarction.
In patients undergoing PCI, there were no significant differences between those receiving drug-eluting stents and those receiving bare-metal stents in the composite outcome of death from any cause and nonfatal spontaneous myocardial infarction. Rates of repeat revascularization were lower in the group receiving drug-eluting stents. (Funded by the Norwegian Research Council and others; NORSTENT ClinicalTrials.gov number, NCT00811772 .).
Bønaa et al. (Tue,) studied this question.